miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1

Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development

(2016) Chengcao Sun et al.   Oncotarget

miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin

(2016) Xuesong Chen et al.   Scientific Reports

Myc and cell cycle control

(2015) Gabriel Bretones et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer

(2015) Chengcheng Zhou et al.   CANCER LETTERS

Adam17, a Target of Mir-326, Promotes Emt-Induced Cells Invasion in Lung Adenocarcinoma

(2015) Ming Cai et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

(2015) Kari R. Fischer et al.   NATURE

Sp1 transcription factor: A long-standing target in cancer chemotherapy

(2015) Carolina Vizcaíno et al.   PHARMACOLOGY & THERAPEUTICS

Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326

(2015) Jing Ke et al.   Oncotarget

LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer

(2015) Ali Zhang et al.   Cell Reports

JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3

(2014) Liliang Li et al.   BREAST CANCER RESEARCH AND TREATMENT

Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target

(2014) Stephen Safe et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells

(2014) Jipeng Li et al.   Molecular Cancer

MicroRNA-326 Regulates Profibrotic Functions of Transforming Growth Factor-β in Pulmonary Fibrosis

(2013) Sudipta Das et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Long noncoding RNAs: Novel insights into hepatocelluar carcinoma

(2013) Yong He et al.   CANCER LETTERS

MicroRNA-326 Functions as a Tumor Suppressor in Glioma by Targeting the Nin One Binding Protein (NOB1)

(2013) Jingxu Zhou et al.   PLoS One

MicroRNAs as potential biomarkers in human solid tumors

(2012) Jun Shen et al.   CANCER LETTERS

Predictive Value of Sp1/Sp3/FLIP Signature for Prostate Cancer Recurrence

(2012) Roble G. Bedolla et al.   PLoS One

MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3

(2011) Bing Feng et al.   CANCER

Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome

(2011) Hongyu Guan et al.   INTERNATIONAL JOURNAL OF CANCER

Sp1 expression regulates lung tumor progression

(2011) T-I Hsu et al.   ONCOGENE

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1

(2011) L Sun et al.   ONCOGENE

MicroRNA-451 Is Involved in the Self-renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem Cells

(2011) Nerea Bitarte et al.   STEM CELLS

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells

(2010) Dimitrios Iliopoulos et al.   MOLECULAR CELL

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1

(2009) Zhongxing Liang et al.   BIOCHEMICAL PHARMACOLOGY